Physician profile
Samarjit Singh
NPI 1689786139
$29,216.76
in general payments reported to CMS, 2019-2025
60 companies · $6,087 in 2025
The $6,087 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,540 · 2020: $2,735 · 2021: $4,394 · 2022: $4,814 · 2023: $3,581 · 2024: $5,066 · 2025: $6,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $1,375 · Honoraria: $1,100 · Education: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,981.60 |
| Consulting Fee | $1,375.00 |
| Honoraria | $1,100.00 |
| Education | $277.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,939.45 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $4,655.19 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $3,698.20 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Becton, Dickinson and Company | $2,475.00 | 2024-2025 | Hemosphere, Alaris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,281.79 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Regeneron Healthcare Solutions, INC. | $1,793.08 | 2021-2025 | Dupixent |
| Mylan Specialty L.P. | $990.73 | 2019-2024 | Yupelri |
| Genzyme Corporation | $926.82 | 2021-2025 | |
| Amgen INC. | $785.62 | 2022-2025 | Tezspire, Tavneos |
| United Therapeutics Corporation | $701.88 | 2020-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $621.99 | 2019-2025 | Prolastin-C Liquid |
| Hill-Rom Services, INC | $450.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $394.86 | 2021-2025 | Opsumit, Uptravi |
| Insmed, INC. | $361.13 | 2019-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $307.82 | 2020-2025 | Glassia, Cuvitru, Hyqvia |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $287.48 | 2025 | Ohtuvayre |
| Philips North America LLC | $285.70 | 2019-2025 | Vest Therapy Und |
| Merck Sharp & Dohme LLC | $279.91 | 2024-2025 | Winrevair |
| Viatris Specialty LLC | $232.85 | 2025 | Yupelri |
| Inspire Medical Systems, INC. | $215.50 | 2019-2025 | Inspire |
| Vifor Pharma, INC. | $215.04 | 2024-2025 | Zemaira |
| Intuitive Surgical, INC. | $190.99 | 2022-2025 | |
| Pfizer INC. | $185.87 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $175.72 | 2021-2025 | Eliquis |
| Stryker Corporation | $164.73 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $122.78 | 2025 | Symplicity G3 |
| Abiomed | $120.55 | 2024 | Impella |
| Gilead Sciences, INC. | $113.04 | 2022-2024 | |
| Pulmonx Corporation | $96.41 | 2020-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Sunovion Pharmaceuticals INC. | $95.15 | 2019-2020 | |
| Inari Medical, INC. | $83.38 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $81.08 | 2023 | Hillrom - Life 2000 Ventilation System |
| Fisher & Paykel Healthcare INC | $77.69 | 2023 | Fisher & Paykel Healthcare |
| Electromed, INC. | $69.02 | 2021-2025 | Smartvest |
| Nabriva Therapeutics, Plc | $54.45 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $53.01 | 2025 | Purified Cortrophin Gel |
| Resmed Corp | $50.00 | 2025 | |
| Allergan, INC. | $43.66 | 2020 | |
| Ambu INC. | $39.07 | 2020 | |
| Genentech USA, INC. | $38.08 | 2019-2022 | |
| Inogen, INC. | $35.05 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Paratek Pharmaceuticals, INC. | $34.56 | 2025 | Nuzyra |
| Liquidia Technologies, INC. | $32.76 | 2025 | Yutrepia |
| Portola Pharmaceuticals, LLC | $28.25 | 2019 | |
| Sobi, INC | $27.52 | 2025 | |
| Harmony Biosciences LLC | $27.38 | 2023 | Wakix |
| Alexion Pharmaceuticals, INC. | $26.46 | 2025 | Strensiq |
| Janssen Pharmaceuticals, INC | $25.27 | 2023 | Xarelto |
| Phadia US INC. | $24.23 | 2024 | Immunocap |
| Sanofi-Aventis U.S. LLC | $23.62 | 2021 | |
| Olympus America INC. | $22.72 | 2021 | |
| Boston Scientific Corporation | $21.79 | 2025 | Enroute Transcarotid Neuroprotection System |
| Lilly USA, LLC | $21.65 | 2025 | Zepbound |
| Veran Medical Technologies, INC. | $20.27 | 2020 | |
| Itamar Medical INC | $18.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.88 | 2022 | |
| Vertiflex, INC. | $15.61 | 2019 | |
| Abbvie INC. | $15.24 | 2021 | |
| Circassia INC. | $11.63 | 2019 | |
| Biomerieux INC | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samarjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.